| SOL-GEL TECHN. IS 1 |
| Israel |
| Gesundheit |
| IL0011417206 / A2JDHD |
| 4SG (Frankfurt) / SLGL (NASDAQ) |
| FRA:4SG, ETR:4SG, 4SG:GR, NASDAQ:SLGL |
| - |
| https://www.sol-gel.com/ |
|
Sol-Gel Technologies Ltd. is a pharmaceutical company specializing in dermatological treatments utilizing its proprietary aerosol-based, drug-delivery platform. Founded in 1997 and headquartered in Israel, Sol-Gel develops topical dermatology product..
>Volltext.. |
| 236.47 Mio. EUR |
| 216.89 Mio. EUR |
| 16.8 Mio. EUR |
| - |
| -5.31 Mio. EUR |
| -1.91 EUR |
| 0.86 Mio. EUR |
| 9.56 Mio. EUR |
| - |
| 3.89 |
| 48.11% |
| 48.96% |
| - |
| - |
| - |
| SOL-GEL, SOL GEL |
| 05.04.26 |
|